这是演示店铺,请务下单付款,避免造成你的财物损失。

为了获得访问"阿拉丁铁蛋"实时聊天框的流畅支持体验,建议您使用Chrome浏览器或选择360浏览器极速模式(如何切换极速模式?),感谢您选择我们!

galectin-3

功能和特点
有货

库存信息

关闭

库存信息

关闭
货号 (SKU) 包装规格 是否现货 价格 数量
rp174094-500μg
500μg 期货 Stock Image
rp174094-1mg
1mg 期货 Stock Image

基本描述

产品名称 galectin-3
别名 galectin 3;GALIG;LGALS2;MAC-2
英文别名 galectin 3;GALIG;LGALS2;MAC-2

产品规格参数

CAS编号和信息 rp174094

质检证书(COA)

质检报告(COA)

输入批号以搜索COA:

产品问答

产品问答

登录提交问题 Hover me 请先登录再提交问题
您提交该产品问题后,我们会在1-2个工作日内给您答复,您可以登录"我的账号",然后点击"我的产品问答"查看答案

参考文献

1. Henderson NC, Sethi T.  (2009)  The regulation of inflammation by galectin-3..  Immunol Rev,  230  (1):  (160-71).  [PMID:19594635]
2. de Boer RA, Voors AA, Muntendam P, van Gilst WH, van Veldhuisen DJ.  (2009)  Galectin-3: a novel mediator of heart failure development and progression..  Eur J Heart Fail,  11  (9):  (811-7).  [PMID:19648160]
3. Streetly MJ, Maharaj L, Joel S, Schey SA, Gribben JG, Cotter FE.  (2010)  GCS-100, a novel galectin-3 antagonist, modulates MCL-1, NOXA, and cell cycle to induce myeloma cell death..  Blood,  115  (19):  (3939-48).  [PMID:20190189]
4. Delaine T, Collins P, MacKinnon A, Sharma G, Stegmayr J, Rajput VK, Mandal S, Cumpstey I, Larumbe A, Salameh BA et al..  (2016)  Galectin-3-Binding Glycomimetics that Strongly Reduce Bleomycin-Induced Lung Fibrosis and Modulate Intracellular Glycan Recognition..  Chembiochem,  17  (18):  (1759-70).  [PMID:27356186]
5. Harazono Y, Kho DH, Balan V, Nakajima K, Zhang T, Hogan V, Raz A.  (2014)  Galectin-3 leads to attenuation of apoptosis through Bax heterodimerization in human thyroid carcinoma cells..  Oncotarget,  (20):  (9992-10001).  [PMID:25393982]
6. DeRoo EP, Wrobleski SK, Shea EM, Al-Khalil RK, Hawley AE, Henke PK, Myers DD Jr, Wakefield TW, Diaz JA.  (2015)  The role of galectin-3 and galectin-3-binding protein in venous thrombosis..  Blood,  125  (11):  (1813-21).  [PMID:25428218]
7. Nakajima K, Kho DH, Yanagawa T, Harazono Y, Hogan V, Chen W, Ali-Fehmi R, Mehra R, Raz A.  (2016)  Galectin-3 Cleavage Alters Bone Remodeling: Different Outcomes in Breast and Prostate Cancer Skeletal Metastasis..  Cancer Res,  76  (6):  (1391-402).  [PMID:26837763]
8. Sumida Y, Yoneda M.  (2018)  Current and future pharmacological therapies for NAFLD/NASH..  J Gastroenterol,  53  (3):  (362-376).  [PMID:29247356]
9. Chan YC, Lin HY, Tu Z, Kuo YH, Hsu SD, Lin CH.  (2018)  Dissecting the Structure-Activity Relationship of Galectin-Ligand Interactions..  Int J Mol Sci,  19  (2):  (1755-70).  [PMID:29382172]

计算器